Electroacupuncture for Nausea,Vomiting,and Myelosuppression in Women Receiving Adjuvant Chemotherapy for Early Breast Cancer: A Randomized Controlled Pilot Trial
Restricted accessResearch articleFirst published online December, 2012
Electroacupuncture for Nausea,Vomiting,and Myelosuppression in Women Receiving Adjuvant Chemotherapy for Early Breast Cancer: A Randomized Controlled Pilot Trial
Acupuncture has been demonstrated as an effective way to control nausea and vomiting induced by chemotherapy but has not been tested in conjunction with optimal use of antiemetic medication.
Objective:
The goal of this study was to explore the feasibility and safety of electroacupuncture (EA) for women with breast cancer, who were receiving chemotherapy.
Design:
The study was a randomized controlled pilot trial.
Setting:
This trial was conducted at a medical oncology clinic at the Royal Prince Alfred Hospital, in Sydney, New South Wales, Australia.
Patients:
Thirty-two women with breast cancer were recruited from a medical oncology clinic between March 2008 and July 2009.
Intervention:
The intervention tested was true EA versus sham EA.
Main Outcome Measures:
The study tested the effect of EA on women with breast cancer who were receiving chemotherapy, with respect to nausea, vomiting, and blood cell counts.
Results:
All but 2 participants completed EA treatment; these two dropouts were 1 from the true EA group and 1 from the sham EA group. No adverse effects of EA were reported. There was no significant difference in nausea and vomiting between the groups. However, there were significant differences in adjusted white blood-cell and neutrophil counts at week 6 in the true EA group, compared to the sham EA group.
Conclusions:
The findings of this trial suggest that EA during chemotherapy is a promising option for controlling side-effects of chemotherapy. An adequately powered, randomized, controlled trial to confirm the effect of EA is, therefore, warranted.
Get full access to this article
View all access options for this article.
References
1.
Australian Institute of Health and Welfare (AIHW). Breast Cancer in Australia: An Overview, 2006. Canberra: AIHW, 2006.
2.
Australian Institute of Health and Welfare (AIHW). Cancer Incidence Projections, Australia 2011 to 2020: Cancer Series No. 66. Cat. No. CAN 62. Canberra: AIHW, 2012.
3.
Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: An overview of the randomised trials. Lancet., 1998; 352,9132:930–942.
4.
RoscoeJA, MorrowGR, AaproMS, MolassiotisA, OlverI. Anticipatory nausea and vomiting. Support Care Cancer., 2011; 19,10:1533–1538.
5.
HellmannK. Preventing the cardiotoxicity of anthracyclines by dexrazoxane. BMJ., 1999; 319,7217:1085–1086.
6.
SpichigerE, Mueller-FroehlichC, DenhaerynckK, StollH, HantikainenV, DoddM. Prevalence of symptoms, with a focus on fatigue, and changes of symptoms over three months in outpatients receiving cancer chemotherapy. Swiss Medical Weekly., 2011; 141:w13303.
7.
Bloechl-DaumB, DeusonRR, MavrosP, HansenM, HerrstedtJ. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. J Clin Oncol., 2006; 24,27:4472–4478.
8.
Baena-CanadaJ, Estalella-MendozaS, Gonzalez-GuerreroM, Exposito-AlvarezI, Rosado-VarelaP, Benitez-RodriguezE. Influence of clinical and biographical factors in the quality of life of women during adjuvant chemotherapy for breast cancer [in Spanish]Revista de Calidad Asistencial, 26,5:299–305.
9.
SalonenP, Kellokumpu-LehtinenP-L, TarkkaM-T, KoivistoA-M, KaunonenM. Changes in quality of life in patients with breast cancer. J Clin Nurs., 2011; 20,1–2:255–266.
10.
BonadonnaG, ValagussaP, MoliterniA, ZambettiM, BrambillaC. Cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: The results of 20 years of follow-up. N Engl J Med., 1995; 332,14:901–906.
11.
KrisMG, HeskethPJ, SomerfieldMRet al.American Society of Clinical Oncology guideline for antiemetics in oncology: Update 2006. J Clin Oncol., 2006; 24,18:2932–2947.
12.
WarrDG, HeskethPJ, GrallaRJet al.Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy. J Clin Oncol., 2005; 23,12:2822–2830.
13.
MartinM, PienkowskiT, MackeyJet al.Adjuvant docetaxel for node-positive breast cancer. N Engl J Med., 2005; 352,22:2302–2313.
14.
PapaldoP, LopezM, MarollaPet al.Impact of five pophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamide. J Clin Oncol., 2005; 23,28:6908–6918.
15.
BonadonnaG, ValagussaP. Dose–response effect of adjuvant chemotherapy in breast cancer. N Engl J Med., 1981; 304,1:10–15.
16.
JacobsonJS, WorkmanSB, KronenbergF. Research on complementary/alternative medicine for patients with beast cancer: A review of the biomedical literature. J Clin Oncol., 2000; 18,3:668–683.
17.
UpchurchD, ChyuL, GreendaleGet al.Complementary and alternative medicine use among American women: Findings from The National Health Interview Survey, 2002. J Womens Health (Larchmt)., 2007; 16,1:102–113.
18.
MatthewsA, SellergrenS, HuoD, ListM, FlemingG. Complementary and alternative medicine use among breast cancer survivors. J Altern Complement Med., 2007; 13,5:555–562.
19.
EzzoJ, VickersA, RichardsonMAet al.Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. J Clin Oncol., 2005; 23,28:7188–7198.
20.
KaptchukTJ. Acupuncture: Theory, efficacy, and practice. Ann Int Med., 2002; 136,5:374–383.
21.
LuWD, MatulonisUA, Doherty-GilmanAet al.Acupuncture for chemotherapy-induced neutropenia in patients with gynecologic malignancies: A pilot randomized, sham-controlled clinical trial. J Altern Complement Med., 2009; 15,7:745–753.
22.
ZhouRX, HuangFL, JiangSR, JiangJC. Acupuncture effects on phagocytosis of white blood cells in humans. Chinese Acupunct Moxibustion., 1987; 6:31–33.
23.
ZhuX, ZhaoHX, LiuH, GanWM. Point block therapy for post-chemo leukopenia: 100 cases report. Chinese Acupunct Moxibustion., 1995; 15:3–4.
24.
LuW, HuD, Dean-ClowerEet al.Acupuncture for chemotherapy-induced leukopenia: Exploratory meta-analysis of randomized controlled trials. J Soc Integr Oncol., 2007; 5,1:1–10.
25.
World Health Organization (WHO). WHO Standard Acupuncture Point Locations in the Western Pacific Region, 1st. Geneva: World Health Organization, 2008.
26.
StreitbergerK, KleinhenzJ. Introducing a placebo needle into acupuncture research. Lancet., 1998; 352,9125:364–365.
27.
MolassiotisA, CoventryPA, StrickerCTet al.Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: The MASCC antiemesis tool. J Pain Symptom Manage., 2007; 34,2:148–159.
28.
LydersenS, FagerlandMW, LaakeP. Recommended tests for association in 2×2 tables. Stat Med., 2009; 28,7:1159–1175.
29.
ShenJ, WengerN, GlaspyJet al.Electroacupuncture for control of myeloablative chemotherapy-induced emesis: A randomized controlled trial. JAMA., 2000; 284,21:2755–2761.
30.
ArranzL, GuayerbasN, SiboniL, De la FuenteM. Effect of acupuncture treatment on the immune function impairment found in anxious women. Am J Chin Med., 2007; 35,1:35–51.
31.
MacPhersonH, ScullionA, ThomasKJ, WaltersS. Patient reports of adverse events associated with acupuncture treatment: A prospective national survey. Qual Saf Health Care., 2004; 13,5:349–355.
32.
MacPhersonH, ThomasK, WaltersS, FitterM. The York acupuncture safety study: Prospective survey of 34,000 treatments by traditional acupuncturists. BMJ., 2001; 323,7311:486–487.
33.
KongJ, GollubRL, RosmanISet al.Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J Neurosci., 2006; 26,2:381–388.
34.
ParienteJ, WhiteP, FrackowiakRSJ, LewithG. Expectancy and belief modulate the neuronal substrates of pain treated by acupuncture. NeuroImage., 2005; 25,4:1161–1167.
35.
LundebergT, LundI, SingA, NäslundJ. Is placebo acupuncture what it is intended to be?Evid Based Complement Alternat Med., 2011; 2011:932407.
36.
LindeK, StrengA, JurgensSet al.Acupuncture for patients with migraine: A randomized controlled trial. JAMA., 2005; 293,17:2118–2125.
37.
DawsonL, ZarinDA, EmanuelEJ, FriedmanLM, ChaudhariB, GoodmanSN. Considering usual medical care in clinical trial design. PLoS Med., 2009; 6,9:e1000111.
